Skip to main content
SpringerLink
Log in

Pharmacokinetic drug interactions between digoxin and antiarrhythmic agents and calcium channel blocking agents: An appraisal of study methodology

  • Focused Section: Congestive Heart Failure
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

While preliminary screening for interactions between new cardiovascular pharmacotherapeutic agents and digoxin can be efficiently and safely conducted in normal healthy volunteers, it is particularly important to detect and quantify drug interactions in patients with varying degrees of cardiac, hepatic and/or renal dysfunction. Much of the previously published literature provides only minimal data to guide clinical practice because of limitations of study design including sample size and measurement techniques.

Important factors that determine the ability of a particular study design to detect a drug interaction with digoxin include the accuracy and precision of the assay method for serum digoxin concentrations, intrasubject and intersubject variability in serum digoxin concentration, and sample size. The format of the trial (chronic versus single digoxin dosing in cardiac patients; chronic verus single digoxin dosing in normal subjects) and the method of assessment of alterations in digoxin handling (formal determination of digoxin clearance, comparison of multiple or single digoxin measurements during various phases of trial) also impact greatly on the clinical relevance of such investigations.

Guidelines for future studies of drug interactions with digoxin in cardiac patients are proposed with particular emphasis on laboratory methods; measurement techniques during baseline, placebo, and active drug phases; calculation of the statistical power of the study; time course of the trial; and assessment of the clinical significance of the findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brown DD, Spector R, Juhl RP. Drug interactions with digoxin.Drugs 1980; 20:198–206.

    PubMed  Google Scholar 

  2. Johnson BF. Drug interactions involving digitalis glycosides. In: Petrie JC ed.Cardiovascular and respiratory disease therapy. Amsterdam: Elsevier/North Holland, 1980:7–20.

    Google Scholar 

  3. Bigger JT, Strauss HC. Digitalis toxicity: drug interactions promoting toxicity and the management of toxicity.Semin Drug Treatment 1972; 2:147–77.

    Google Scholar 

  4. Smith TW, Antman EM, Friedman PL, et al. Digitalis glycosides: mechanisms and manifestations of toxicity (Part I).Prog Cardiovasc Dis 1984; 27:413–41.

    Article  Google Scholar 

  5. Leahey EB Jr, Reiffel JA, Drusin RE, et al. Interaction between digoxin and quinidine.JAMA 1978; 240:533–34.

    Article  PubMed  Google Scholar 

  6. Doering W, Konig E. Ansteig der Digoxinkonzentration in Serum unter Chinidinmedikation.Med Klin 1978; 73:1085–88.

    PubMed  Google Scholar 

  7. Ejvinsson G. Effect of quinidine on plasma concentrations of digoxin.Br Med J 1978; 1:279–80.

    PubMed  Google Scholar 

  8. Reiffel JA, Leahey EB Jr, Drusin RE, et al. A digoxin/quinidine adverse drug interaction.Am J Cardiol 1978; 41:368.

    Article  Google Scholar 

  9. Leahey EB Jr, Bigger JT, Butler VP Jr, et al. Quinidine-digoxin interaction. Time course and pharmacokinetics.Am J Cardiol 1981; 48:1141–46.

    Article  PubMed  Google Scholar 

  10. Hager WD, Fenser P, Mayersohn M, et al. Digoxinquinidine interaction. Pharmacokinetic evaluation.N Engl J Med 1979; 300:1238–41.

    PubMed  Google Scholar 

  11. Schenck-Gustaffson, K. The quinidine-digoxin interaction. Effects of quinidine on pharmacokinetics and pharmacodynamics of digoxin. (Thesis, Karolinska Institute, Stockholm), Dahlberg & Co., 1982.

    Google Scholar 

  12. Antman EM, Arnold JMO, Friedman, PL, et al. Drug interactions with cardiac glycosides: evaluation of a possible digoxin-ethmozine pharmacokinetic interaction.J Cardiovasc Pharm 1987; 9:622–627.

    Google Scholar 

  13. Podrid PJ, Lyakishev A, Lown B, et al. Ethmozine, a new antiarrhythmic drug for suppressing ventricular premature complexes.Circulation 1980; 61:450–57.

    PubMed  Google Scholar 

  14. Morganroth J, Pearlman AS, Dunkman WB, et al. Ethmozine: a new antiarrhythmic agent developed in the USSR. Efficacy and tolerance.Am Heart J 1979; 98:621–28.

    Article  PubMed  Google Scholar 

  15. Doering W. Quinidine-digoxin interaction.N Engl J Med 1977; 39:213–16.

    Google Scholar 

  16. Mungall DR, Robichaux RP, Perry W, et al. Effects of quinidine on serum digoxin concentration.Ann Intern Med 1980; 93:689–93.

    PubMed  Google Scholar 

  17. Ochs HR, Bodem G, Greenblatt DJ. Impairment of digoxin clearance by co-administration of guinidine.J Clin Pharmacol 1981; 21:396–400.

    PubMed  Google Scholar 

  18. Schenck-Gustafsson K, Dahlquist R. Pharmacokinetics of digoxin in patients subjected to the quinidine-digoxin interaction.Br J Clin Pharmacol 1981; 11:181–86.

    PubMed  Google Scholar 

  19. Klein HO, Lang R, Weiss E, et al. The influence of verapamil on serum digoxin concentration.Circulation 1982; 65:998–1003.

    PubMed  Google Scholar 

  20. Schenck-Gustafsson K, Juhlin-Dannfelt A, Dahlquist R. Renal function and digoxin clearance during quinidine therapy.Clin Physiol 1982; 2:401–04.

    PubMed  Google Scholar 

  21. Pedersen KE, Christiansen BD, Klitgaard NA, Nielsen-Kudsk F. Effect of guinidine on digoxin bioavailability.Eur J Clin Pharmacol 1983; 24:41–47

    Article  PubMed  Google Scholar 

  22. Nademanee K, Kannan R, Hendrickson J, et al. Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications.J Am Coll Cardiol 1984; 4:111–16.

    PubMed  Google Scholar 

  23. Leahey EB Jr, Reiffel JA, Giardina EVG, Bigger JT. The effect of quinidine and other oral antiarrhythmic drugs on serum digoxin.Ann Intern Med 1980; 9:605–08.

    Google Scholar 

  24. Wellens HJJ, Gorgels AP, Braat SJ, et al. Effects of oral disopyramide on serum digoxin levels. A prospective study.Am Heart J 1980; 100:934–35.

    Article  PubMed  Google Scholar 

  25. Moysey JO, Jaggarao NSV, Grundy EN, Chamberlain DA. Amiodarone increases plasma digoxin concentrations.Br Med J 1981; 282:272.

    Google Scholar 

  26. Schwartz JB, Keefe D, Kates RE, et al. Acute and chronic pharmacodynamic interaction of verapamil and digoxin in atrial fibrillation.Circulation 1982; 65:1163–70.

    PubMed  Google Scholar 

  27. Reiffel JA, Leahey EB Jr, Drusin RE, et al. A previously unrecognized drug interaction between quinidine and digoxin.Clin Cardiol 1979; 2:40–42.

    PubMed  Google Scholar 

  28. Klein HO, Lang R, Di Segni E, Kaplinksy E. Verapamildigoxin interaction.N Engl J Med 1980; 303:160.

    Google Scholar 

  29. Schenck-Gustafsson K, Jogestrand T, et al. Effect of quinidine on digoxin concentration of skeletal muscle and serum in patients with atrial fibrillation.N Engl J Med 1981; 305:209.

    PubMed  Google Scholar 

  30. Doering W, Fichtl B, Bermann M, Besenfelder E. Quinidine-digoxin interaction: evidence for involvement of an extrarenal mechanism.Eur J Clin Pharmacol 1982; 21:281–85.

    Article  PubMed  Google Scholar 

  31. Lessem J, Bellinetto A. Interaction between digoxin and the calcium antagonists nicardipine and tiapamil.Clin Ther 1983; 5:595–602.

    PubMed  Google Scholar 

  32. Koren G, Hesslein PS, Macleod SM. Digoxin toxicity associated with amiodarone therapy in children.J Pediatr 1984; 104:467–70.

    PubMed  Google Scholar 

  33. Oetgen WJ, Sobol SM, Tri TB, et al. Amiodarone-digoxin interaction, clinical and experimental observation.Chest 1984; 86:75–79.

    PubMed  Google Scholar 

  34. Schwartz JB, Raizner A, Akers S. The effect of nifedipine on serum digoxin concentrations in patients.Am Heart J 1984; 107:669–73.

    Article  PubMed  Google Scholar 

  35. Day T, Hunt D. Interaction between mexiletine and digoxin.Med J Aust 1983; 2:630.

    PubMed  Google Scholar 

  36. Fenster PE, Hager WD, Perrier D, et al. Digoxin-quinidine interaction in patients with chronic renal failure.Circulation 1982; 66:1277–80.

    PubMed  Google Scholar 

  37. Belz GG, Doering W, Munkes R, Matthews J. Interaction between digoxin and calcium antagonists and antiarrhythmic drugs.Clin Pharmacol Ther 1984; 36:19–24.

    PubMed  Google Scholar 

  38. Risler T, Burk M, Peters U, et al. On the interaction between digoxin and disopyramide.Clin Pharmacol Ther 1983; 34:176–80.

    PubMed  Google Scholar 

  39. Schwartz JB, Migliore PJ. Effect of nifedipine on serum digoxin concentration and renal digoxin clearance.Clin Pharmacol Ther 1984; 36:19–24.

    PubMed  Google Scholar 

  40. Rameis H, Magometschnigg D, Ganzinger U. The diltiazem-digoxin interaction.Clin Pharmacol Ther 1984; 36:183–89.

    PubMed  Google Scholar 

  41. Hirsh PD, Weiner HJ, North RRL. Further insights into digoxin-quinidine interaction: lack of correlation between serum digoxin concentration and inotropic state of the heart.Am J Cardiol 1980; 46:863–68.

    Article  PubMed  Google Scholar 

  42. Doering W. Effect of co-administration of verapamil and quinidine on serum digoxin concentration.Eur J Clin Pharm 1983; 25:517–21.

    Article  Google Scholar 

  43. Saris SD, Lowenthal DT, Affrime M, et al. Steady state digoxin concentration during oral mexiletine administration.Current Ther Res 1983; 34:662.

    Google Scholar 

  44. Lewis GP, Holtzman HL. Interaction of flecainide with digoxin and propranolol.Am J Cardiol 1984; 53:52B-57B.

    Article  PubMed  Google Scholar 

  45. Belz GG, Aust PE, Munkes R. Digoxin plasma concentrations and nifedipine.Lancet 1981; 1:844–45.

    Article  Google Scholar 

  46. Schenck-Gustafsson K, Jogestrand T, Brodin LA, et al. Cardiac effects of treatment with quinidine and digoxin, alone and in combination.Am J Cardiol 1983; 51:777–82.

    PubMed  Google Scholar 

  47. Steiness E, Waldorff S, Hansen PB, et al. Reduction of digoxin-induced inotropism during quinidine administration.Clin Pharmacol Ther 1980, 27:791–95.

    PubMed  Google Scholar 

  48. Wandell M, Powell JR, Hager WD, et al. Effect of quinidine on digoxin kinetics.Clin Pharmacol Ther 1980; 28:425–30.

    PubMed  Google Scholar 

  49. Hager WD, Mayersohn M, Graves PE. Digoxin bioavailability during quinidine administration.Clin Pharmacol Ther 1981; 30:594–98.

    PubMed  Google Scholar 

  50. Pedersen KE, Dorph-Pedersen A, Hvidt S, et al. Digoxin-verapamil interaction.Clin Pharmacol Ther 1981; 30:311–16.

    PubMed  Google Scholar 

  51. Pedersen KE, Dorph-Pedersen A, Hvidt S, et al. Effect of nifedipine on digoxin kinetics in healthy subjects.Clin Pharmacol Ther 1982; 32:562–65.

    PubMed  Google Scholar 

  52. Pedersen KE, Thayssen P, Klitgaard NA, et al. Influence of verapamil on the inotropism and pharmacokinetics of digoxin.Eur J Clin Pharmacol 1983; 25:199–206.

    PubMed  Google Scholar 

  53. Fenster PE, Hager WD, Goodman MM. Digoxin-quinidine-spironolactone interaction.Clin Pharmacol Ther 1984; 36:70–73.

    PubMed  Google Scholar 

  54. Yoshida A, Fugita M, Kurosawa N, et al. Effect of diltiazem on plasma level and urinary excretion of digoxin in health subjects.Clin Pharmacol Ther 1984; 35:681–85.

    PubMed  Google Scholar 

  55. Fenster PE, White NW Jr, Hanson CD. Pharmacokinetic evaluation of the digoxin-amiodarone interaction.J Am Coll Cardiol 1985; 4:108–12.

    Google Scholar 

  56. McFarland R, Moeller VR, Pieniaszek HJ Jr., et al. Assessment of the potential pharmacokinetic interaction between digoxin and ethmozine.J Clin Pharmacol 1985; 25:138–43.

    PubMed  Google Scholar 

  57. Grasela TH, Antal EJ, Townsend RJ, Smith RB. An evaluation of population pharmacokinetics in therapeutic trials. Part I. Comparison of methodologies.Clin Pharmacol Ther 1986; 39:605–12.

    PubMed  Google Scholar 

  58. Bigger JT. The quinidine-digoxin interaction.Int J Card 1918; 1:109–16.

    Article  Google Scholar 

  59. Sheiner LB, Stanski DR, Vozeh S, et al. Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.Clin Pharmacol Ther 1979; 25:358–71.

    PubMed  Google Scholar 

  60. Whiting B, Holford NHG, Sheiner LB. Quantitative analysis of the disopyramide concentration-effect relationship.Br J Clin Pharmacol 1980; 9:67–75.

    PubMed  Google Scholar 

  61. Kelman AW, Whiting B. Modeling of drug response in individual subjects.J Pharmacokinetics and Biopharmaceutics 1980; 8:115–30.

    Article  Google Scholar 

  62. Sheiner LB, Beal SL. Bayesian individualization of pharmacokinetics: simple implemention and comparison with non-Bayesian methods.J Pharm Sci 1982; 71:1344–48.

    PubMed  Google Scholar 

  63. Sheiner LB, Rosenberg B, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data.J Pharmacokinet Biopharm 1977; 5:445–79.

    Article  PubMed  Google Scholar 

  64. Marcus FI. Pharmacokinetic interactions between digoxin and other drugs.J Am Coll Cardiol 1985; 5:82A-90A.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Division and Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Elliott M. Antman M.D., J. Malcolm O. Arnold, Peter L. Friedman & Thomas W. Smith

Authors
  1. Elliott M. Antman M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Malcolm O. Arnold
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter L. Friedman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Thomas W. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Antman, E.M., Arnold, J.M.O., Friedman, P.L. et al. Pharmacokinetic drug interactions between digoxin and antiarrhythmic agents and calcium channel blocking agents: An appraisal of study methodology. Cardiovasc Drug Ther 1, 183–189 (1987). https://doi.org/10.1007/BF02125472

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02125472

Key words

Search

Navigation